Overview
The infusion market is undergoing significant change in 2026, fueled by Medicare drug price negotiation, site-of-care steering, and evolving drug acquisition models. In this webinar, we’ll examine the evolving roles of buy-and-bill and white bagging, the continued movement of therapies from the medical to pharmacy benefit, and the increasing compliance risks associated with these developments.
Discussion topics include:
- Buy-and-bill vs. white bagging considerations
- Impact of Medicare pricing and margin pressure
- Site-of-care steering and benefit design shifts
- Healthcare fraud and abuse considerations
Continuing Legal Education (CLE) credit is pending. McDermott Will & Schulte is an approved provider and can provide credit in California, Illinois, and New York. McDermott Will & Schulte is a sponsor and will apply for credit in Delaware, Florida, Georgia, Tennessee, Texas, and Virginia when lawyers licensed in these jurisdictions are in attendance. We can issue reciprocal credit for lawyers licensed in Connecticut and New Jersey. For all other jurisdictions not listed, attendees will be provided with a Universal Certificate of Attendance which they may use to self-apply for CLE credit in their state of admission. Attendees should contact their state’s CLE Board for current rules, regulations, and guidance